| Net Cash Provided by (Used in) Operating Activities |
$8,981 |
USD |
7.1% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
7,825,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$20,000 |
USD |
108% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$13,835 |
USD |
0.48% |
Q3 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$13,769 |
USD |
|
Q3 2024 |
FY 2024 |
| Depreciation |
$0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$961 |
USD |
0% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$65,879 |
USD |
0.48% |
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$25,425 |
USD |
0% |
Q3 2025 |
FY 2025 |